Today: 20 March 2026
Subscribe
Browse Category

Stock Market 15 January 2026

IBM stock slides as Sovereign Core rollout sharpens focus on ‘digital sovereignty’ ahead of Jan. 28 earnings

IBM stock slides as Sovereign Core rollout sharpens focus on ‘digital sovereignty’ ahead of Jan. 28 earnings

IBM shares fell 2.7% to $300.56 in afternoon trading Thursday after a volatile session. The company launched “Sovereign Core,” new software aimed at enterprises and governments needing local control over cloud and AI workloads. A tech preview begins in February, with general release planned for mid-2026. Investors await IBM’s quarterly results on January 28 for further guidance.
15 January 2026
···
Why D-Wave Quantum (QBTS) stock is slipping today as quantum IPO plans grab attention

Why D-Wave Quantum (QBTS) stock is slipping today as quantum IPO plans grab attention

D-Wave Quantum shares fell 0.5% to $29.99 Thursday afternoon, reversing gains from the previous session. Honeywell said Quantinuum plans to file a confidential S-1 for a potential IPO. D-Wave’s $550 million Quantum Circuits acquisition is expected to close by late January. Trading volume for D-Wave reached about 32 million shares.
15 January 2026
······
Coca-Cola stock dips today as Coke taps first chief digital officer ahead of earnings

Coca-Cola stock dips today as Coke taps first chief digital officer ahead of earnings

Coca-Cola shares fell about 1% Thursday after the company announced a leadership overhaul, including its first Chief Digital Officer and shifting commercial duties away from the CFO. The changes take effect March 31, as Henrique Braun prepares to succeed James Quincey as CEO. Investors await the Feb. 10 earnings report and Feb. 17 CAGNY presentation for more details on strategy. PepsiCo shares rose 0.6%.
15 January 2026
···
Circle stock (CRCL) slides as Senate stalls crypto bill, putting stablecoin rewards back in focus

Circle stock (CRCL) slides as Senate stalls crypto bill, putting stablecoin rewards back in focus

Circle shares fell 4.5% to $80.97 Thursday after a U.S. Senate panel delayed action on a crypto market-structure bill opposed by Coinbase. CEO Brian Armstrong warned the draft could end stablecoin rewards for customers. Crypto stocks broadly declined, with Coinbase down 3.2%. Investors are watching for signals ahead of the Federal Reserve’s January meeting.
15 January 2026
····
Marvell (MRVL) stock rises as RBC starts coverage, cites AWS Trainium and data-center demand

Marvell (MRVL) stock rises as RBC starts coverage, cites AWS Trainium and data-center demand

Marvell shares rose about 1% to $82.04 after RBC Capital Markets initiated coverage with an Outperform rating and $105 price target. The move followed TSMC’s strong earnings, which lifted chip stocks broadly. RBC cited firm orders from Amazon Web Services’ Trainium3 program and highlighted Marvell’s advances in photonics. Investors remain focused on sustained AI chip demand and Marvell’s upcoming earnings report.
15 January 2026
···
PepsiCo stock ticks up as UBS trims target and inflation keeps investors on edge

PepsiCo stock ticks up as UBS trims target and inflation keeps investors on edge

PepsiCo shares rose 0.6% to $146.80 in Thursday afternoon trading, building on Wednesday’s 1.7% gain. UBS cut its price target to $170 but kept a Buy rating, citing a tougher environment for staples. Investors are watching for early February earnings amid rising food inflation and concerns over pricing power. Siemens reported PepsiCo increased Gatorade plant throughput 20% using AI-powered digital twins.
15 January 2026
··
Booking Holdings stock steadies as U.S. visa move keeps travel names on edge (BKNG)

Booking Holdings stock steadies as U.S. visa move keeps travel names on edge (BKNG)

Booking Holdings shares were flat Thursday after a 2.4% drop Wednesday, as investors reacted to the U.S. suspension of immigrant visa processing for 75 countries starting Jan. 21. The move has pressured travel stocks and intensified scrutiny of U.S. entry policies ahead of the 2026 World Cup. Booking traded at $5,183.21 in the afternoon, about 11% below its 52-week high.
15 January 2026
····
Merck stock slips as FDA fast-track delays grab attention ahead of Feb. 3 earnings

Merck stock slips as FDA fast-track delays grab attention ahead of Feb. 3 earnings

Merck shares fell 0.2% to $110.75 Thursday after the FDA delayed decisions in its new voucher fast-track program, according to Reuters. The FDA postponed reviews of drugs from Sanofi, Disc Medicine, and Eli Lilly, citing safety concerns. Investors are watching for Merck’s Feb. 3 earnings and updates on its drug pipeline. Healthcare stocks broadly declined, with Eli Lilly down 3.6%.
15 January 2026
···
Amphenol (APH) stock jumps 6% as Goldman lifts target and company tees up ADC India open offer

Amphenol (APH) stock jumps 6% as Goldman lifts target and company tees up ADC India open offer

Amphenol shares jumped 6.4% to $156.13 after the company filed an open offer to buy 26% of ADC India, following its $10.5 billion CommScope deal. Goldman Sachs, BofA, and UBS raised price targets, citing strong data-center demand. The open offer totals about $16.4 million if fully accepted. Investors await Amphenol’s Jan. 28 earnings call for updates on integration and order trends.
15 January 2026
·
Bloom Energy stock jumps 8% as EIA flags data-center power surge

Bloom Energy stock jumps 8% as EIA flags data-center power surge

Bloom Energy shares jumped 8% to $144.11 Thursday, hitting a new intraday high amid investor focus on rising electricity demand from data centers. The move follows American Electric Power’s $2.65 billion deal to buy Bloom’s fuel cells for a Wyoming facility. Broader clean energy stocks also rose, while Bloom’s rivals fell. The EIA will release updated U.S. energy demand forecasts on February 10.
15 January 2026
···
Pfizer stock edges higher as vaccine-policy jitters and obesity race frame the next catalyst

Pfizer stock edges higher as vaccine-policy jitters and obesity race frame the next catalyst

Pfizer shares rose 0.3% to $25.67 Thursday as investors weighed U.S. vaccine policy debates and the company’s growth outlook. The stock moved between $25.26 and $25.67 with 22.3 million shares traded. Pfizer will report Q4 results on Feb. 3, with guidance projecting 2026 revenue of $59.5–$62.5 billion and lower COVID-19 product sales. Competition in obesity drugs and AI-driven drug discovery remain in focus.
15 January 2026
····
1 … 482 483 484 485 486 … 1,356

Stock Market Today

  • Is General Electric Stock Fairly Valued After Recent Pullback?
    March 20, 2026, 11:49 AM EDT. General Electric's (GE) shares have dropped 4.9% in the past week and 10.8% over 30 days, yet the stock remains close to its intrinsic value. A Discounted Cash Flow (DCF) model estimates GE's fair value at about $272.33 per share, slightly below the current $291.61 price, suggesting the shares are roughly 7.1% overvalued. Despite a 43.8% return over the last year, GE's performance is now lagging behind peers amid shifts in capital goods, regulation, and company factors. Investors should monitor free cash flow estimates and valuation metrics like the price-to-earnings ratio to gauge potential risks and opportunities.
Go toTop